<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Surg.</journal-id>
<journal-title>Frontiers in Surgery</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Surg.</abbrev-journal-title>
<issn pub-type="epub">2296-875X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fsurg.2024.1333646</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Surgery</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>A nomogram for predicting the probability of femoral head collapse in convalescent SARS patients with glucocorticoid-induced osteonecrosis of the femoral head: an 18-year population-based retrospective cohort study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Qu</surname><given-names>Rundong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/2355535/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Gao</surname><given-names>Fuqiang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/1837736/overview" />
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Sun</surname><given-names>Wei</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/2221196/overview" />
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Zirong</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><label><sup>1</sup></label><institution>Department of Orthopaedics, Capital Medical University China-Japan Friendship School of Clinical Medicine</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<aff id="aff2"><label><sup>2</sup></label><institution>Department of Orthopaedics, Centre for Osteonecrosis and Joint-Preserving &#x0026; Reconstruction, China-Japan Friendship Hospital</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<aff id="aff3"><label><sup>3</sup></label><institution>Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania</institution>, <addr-line>Philadelphia</addr-line>, <addr-line>PA</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited by:</bold> Fanxiao Liu, Shandong Provincial Hospital, China</p></fn>
<fn fn-type="edited-by"><p><bold>Reviewed by:</bold> Xin Wang, People&#x2019;s Liberation Army General Hospital, China</p>
<p>Hongting Jin, Zhejiang Chinese Medical University, China</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Fuqiang Gao <email>gaofuqiang@bjmu.edu.cn</email> Wei Sun <email>sunwei@zryhyy.com.cn</email></corresp>
</author-notes>
<pub-date pub-type="epub"><day>30</day><month>05</month><year>2024</year></pub-date>
<pub-date pub-type="collection"><year>2024</year></pub-date>
<volume>11</volume><elocation-id>1333646</elocation-id>
<history>
<date date-type="received"><day>20</day><month>03</month><year>2024</year></date>
<date date-type="accepted"><day>14</day><month>05</month><year>2024</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2024 Qu, Gao, Sun and Li.</copyright-statement>
<copyright-year>2024</copyright-year><copyright-holder>Qu, Gao, Sun and Li</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<sec><title>Background</title>
<p>This study aimed to develop a nomogram capable of predicting the probability of femoral head collapse based on an 18-year follow-up cohort of convalescent severe acute respiratory syndrome (SARS) patients with glucocorticoid-induced osteonecrosis of the femoral head (ONFH).</p>
</sec>
<sec><title>Methods</title>
<p>Data on the natural history of 120 patients (205 hips) who underwent glucocorticoid-induced ONFH at China-Japan Friendship Hospital (CJFH) in 2003 were retrospectively collected. Follow-up was conducted from June 2003 to October 2021. A nomogram was developed in a training cohort and validated in another cohort.</p>
</sec>
<sec><title>Results</title>
<p>A total of 205 hips were included for analysis, with 143 hips in the training cohorts and 62 hips in the validation cohorts. After 18 years of follow-up, 53 femoral heads collapsed, while 152 femoral heads spontaneously repaired to some extent (necrotic areas reduced or vanished). Following multivariate regression analysis, the Association Research Circulation Osseous (ARCO) staging, necrosis index (NI), and CJFH Classification were entered into the nomogram. The nomogram showed robust discrimination, with an AUC of 0.907 (95&#x0025; CI: 0.85&#x2013;0.96). The calibration curves showed an agreement between the probability as predicted by the nomogram and the actual probability. Application of the nomogram in the validation cohort also yielded good discrimination (AUC, 0.876, 95&#x0025; CI: 0.7751&#x2013;0.9761) and calibration.</p>
</sec>
<sec><title>Conclusion</title>
<p>The nomogram successfully predicted femoral head collapse in glucocorticoid-induced ONFH. With the nomogram, the prognosis for an individual patient with glucocorticoid-induced ONFH can be determined, which can lead to a rational therapeutic choice.</p>
</sec>
</abstract>
<kwd-group>
<kwd>nomogram</kwd>
<kwd>ONFH</kwd>
<kwd>glucocorticoid</kwd>
<kwd>disease development</kwd>
<kwd>precision medicine</kwd>
</kwd-group>
<contract-num rid="cn001">2022-NHLHCRF-PY-20</contract-num>
<contract-num rid="cn002">2022-HX-JC-7</contract-num>
<contract-num rid="cn003">81672236, 81871830</contract-num>
<contract-num rid="cn004">7182146</contract-num>
<contract-num rid="cn005">RZ2020-02</contract-num>
<contract-num rid="cn006">ZRJY2021-GG12</contract-num>
<contract-sponsor id="cn001">National High Level Hospital Clinical Research Funding</contract-sponsor>
<contract-sponsor id="cn002">China-Japan Friendship Hospital Horizontal Project/Spontaneous Research Funding</contract-sponsor>
<contract-sponsor id="cn003">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content></contract-sponsor>
<contract-sponsor id="cn004">Beijing Natural Science Foundation<named-content content-type="fundref-id">10.13039/501100004826</named-content></contract-sponsor>
<contract-sponsor id="cn005">BRC-BC (Biomedical Translational Engineering Research Center of BUCT-CJFH)</contract-sponsor>
<contract-sponsor id="cn006">China-Japan Friendship Hospital<named-content content-type="fundref-id">10.13039/501100012173</named-content></contract-sponsor>
<counts>
<fig-count count="6"/>
<table-count count="3"/><equation-count count="0"/><ref-count count="35"/><page-count count="0"/><word-count count="0"/></counts><custom-meta-wrap><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Orthopedic Surgery</meta-value></custom-meta></custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro"><label>1</label><title>Introduction</title>
<p>Osteonecrosis of the femoral head (ONFH) is a common and difficult-to-treat orthopedic disease, and glucocorticoid-induced ONFH is one type of non-traumatic ONFH occurring after pulsed and/or long-term corticosteroids (CS) treatment for infectious diseases [such as severe acute respiratory syndrome (SARS)] and rheumatoid diseases [such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE)]. In a recent large-scale epidemiological survey in China, the cumulative number of patients with non-traumatic ONFH reached 8.12 million among the Chinese population (<xref ref-type="bibr" rid="B1">1</xref>). In the spring of 2003, SARS spread in China (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). To save the lives of these patients, high doses of CS were used. Consequently, many patients with osteonecrosis were found in the period of rehabilitation (<xref ref-type="bibr" rid="B4">4</xref>).</p>
<p>The patients with glucocorticoid-induced ONFH are usually younger. Without effective treatment, about 60&#x0025;&#x2013;80&#x0025; of ONFH will progress to femoral head collapse within 1&#x2013;5 years (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). After the collapse, most hip joints will progress to the point where artificial joint replacement is required within 2&#x2013;3 years (<xref ref-type="bibr" rid="B5">5</xref>). Considering that patients are often young and active, the long-term efficacy of artificial joints is still unpredictable, and the THAs generally have a higher rate of revision and worse outcomes than those performed for primary hip osteoarthritis (<xref ref-type="bibr" rid="B7">7</xref>). Therefore, it is significant for clinical doctors to make individualized treatment plans for joint preservation to delay or ideally prevent artificial joint replacement so that patients can retain well-functioning native joints for as long as possible. To explore the progressive regular pattern of non-traumatic ONFH and establish a reliable and accessible new classification for clinical use, Li et al. (<xref ref-type="bibr" rid="B8">8</xref>) proposed the China-Japan Friendship Hospital (CJFH) Classification based on the three pillars structure, which emphasizes the significance of the lateral pillar. The proposal of CJFH Classification was inspired by the pillars theory of the Herring classification of Legg&#x2013;Calv&#x00E9;&#x2013;Perthes disease (<xref ref-type="bibr" rid="B9">9</xref>).</p>
<p>In recent years, there has been increasing emphasis on studies aiming to predict the collapse of the femoral head in ONFH. These studies encompass various methods of radiographic analysis, stress distribution analysis, and finite element analysis (<xref ref-type="bibr" rid="B10">10</xref>). The majority of these studies are single-factor analysis. There is still a lack of a specific, practical, and accessible predictive model. Therefore, the development of a predictive model that incorporates factors associated with glucocorticoid-induced ONFH becomes desirable. Among the available models, a nomogram can provide an individualized, evidence-based, highly accurate prognosis estimation. Nomograms are considered user-friendly tools that aid in management-related decision-making processes (<xref ref-type="bibr" rid="B11">11</xref>). Meanwhile, there has been no study of nomograms to predict the collapse of the femoral head in glucocorticoid-induced ONFH before. Thus, this study aims to develop a nomogram to predict the probability of femoral head collapse in patients with glucocorticoid-induced ONFH in the early stage.</p>
</sec>
<sec id="s2" sec-type="methods"><label>2</label><title>Methods</title>
<sec id="s2a"><label>2.1</label><title>Study design</title>
<p>This was a retrospective cohort study in patients with glucocorticoid-induced ONFH caused by pulsed and/or long-term CS treatment during the period of SARS. We conducted a regular follow-up (once a year) from June 2003 to October 2021 in CJFH. All the participants were medical personnel in convalescence of SARS. The study was approved by the Institutional Ethics Committee of the CJFH. Informed consent was obtained from all patients for their data to be used for research.</p>
<p>Inclusion criteria were as follows: (1) patients aged 18&#x2013;65 years, of any gender; (2) patients who received pulsed and/or long-term corticosteroid (CS) treatment during the outbreak of SARS and subsequently developed glucocorticoid-induced ONFH; (3) patients with diagnosis confirmed at CJFH through clinical evaluation and imaging (e.g., MRI, CT); (4) patients who provided consent for the use of their medical data for research purposes; and (5) medically stable patients capable of undergoing follow-up.</p>
<p>Exclusion criteria were as follows: (1) patients with severe primary diseases or conditions unsuitable for the study, such as uncontrolled systemic infections or advanced malignancies; (2) patients with prior ONFH diagnosis before SARS corticosteroid treatment; (3) pregnant or lactating women; (4) patients with other etiologies of ONFH apart from glucocorticoid-induced, including but not limited to alcohol abuse, traumatic injury, or other systemic conditions predisposing to ONFH; (5) patients with conditions or comorbidities that may confound the study outcomes or interfere with the interpretation of results; (6) patients who are unable or unwilling to provide consent or participate in follow-ups; and (7) patients with contraindications to MRI, such as incompatible implants or claustrophobia.</p>
<p>These elaborations provide a comprehensive overview of the specific criteria for inclusion and exclusion, ensuring the selection of appropriate participants for the study while minimizing confounding factors. From July 2003 to February 2004, we performed a radiological investigation on patients who suffered from SARS in the spring of 2003, including a comprehensive evaluation of systemic joints using magnetic resonance imaging (MRI), computed tomography (CT), and radiography. The films were evaluated by qualified radiologists and orthopedists, respectively, and an agreement for the final diagnosis may be obtained by a cooperative discussion of the films resulting in discrepant opinions from the two independent professionals (<xref ref-type="bibr" rid="B12">12</xref>). The diagnosis criteria of ONFH was a limited subchondral linear-shaped low signal intensity in T1-weighted images (T1WIs) or a &#x201C;double-line sign&#x201D; in T2-weighted images (T2WIs) on MRI.</p>
</sec>
<sec id="s2b"><label>2.2</label><title>Study variables</title>
<p>The variables in this study are reported in <xref ref-type="table" rid="T1">Table&#x00A0;1</xref>, including age at diagnosis, height at diagnosis, weight at diagnosis, BMI at diagnosis, sex, accumulated dose of CS, Association Research Circulation Osseous (ARCO) Staging, necrosis index (NI), and CJFH (CJFH) Classification. According to the involvement of the lesion in pillars, the CJFH Classification consists of three major types (M, C, and L) and three subtypes (L1, L2, and L3) (<xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref>). The mean age was 34.58 years (range: 20&#x2013;62 years), mean height at diagnosis was 165.6&#x2005;cm (range: 156&#x2013;180&#x2005;cm), mean weight at diagnosis was 62.5&#x2005;kg (range: 51&#x2013;160&#x2005;kg), mean BMI at diagnosis was 22.7&#x2005;kg/m<sup>2</sup> (range: 18.2&#x2013;26.7&#x2005;kg/m<sup>2</sup>), and mean accumulated dose of CS was 5,113.75&#x2005;mg (range: 800&#x2013;16,000&#x2005;mg).</p>
<table-wrap id="T1" position="float"><label>Table 1</label>
<caption><p>Participant characteristics.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Variables</th>
<th valign="top" align="center">Training</th>
<th valign="top" align="center">Validation</th>
<th valign="top" align="center"><italic>P</italic>-value</th>
</tr>
<tr>
<th valign="top" align="center"/>
<th valign="top" align="center">(<italic>n</italic>&#x2009;&#x003D;&#x2009;143)</th>
<th valign="top" align="center">(<italic>n</italic>&#x2009;&#x003D;&#x2009;62)</th>
<th valign="top" align="center"/>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" colspan="4">Sex</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Male</td>
<td valign="top" align="center">56 (39.16&#x0025;)</td>
<td valign="top" align="center">22 (35.48&#x0025;)</td>
<td valign="top" align="center">0.73</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Female</td>
<td valign="top" align="center">87 (60.84&#x0025;)</td>
<td valign="top" align="center">40 (64.52&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Height, mean (SD), cm</td>
<td valign="top" align="center">165.8 (5.5)</td>
<td valign="top" align="center">165.2 (5.3)</td>
<td valign="top" align="center">0.62</td>
</tr>
<tr>
<td valign="top" align="left">Weight, mean (SD), kg</td>
<td valign="top" align="center">62.6 (7.4)</td>
<td valign="top" align="center">62.4 (7.1)</td>
<td valign="top" align="center">0.41</td>
</tr>
<tr>
<td valign="top" align="left">BMI, mean (SD), kg/m<sup>2</sup></td>
<td valign="top" align="center">22.7 (1.7)</td>
<td valign="top" align="center">22.8 (1.7)</td>
<td valign="top" align="center">0.88</td>
</tr>
<tr>
<td valign="top" align="left">Age, mean (SD), years</td>
<td valign="top" align="center">34.7 (9.3)</td>
<td valign="top" align="center">34.3 (9.1)</td>
<td valign="top" align="center">0.15</td>
</tr>
<tr>
<td valign="top" align="left" colspan="4">Accumulated dose of CS</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;&#x2264;2,000&#x2009;mg</td>
<td valign="top" align="center">15 (10.49&#x0025;)</td>
<td valign="top" align="center">6 (9.68&#x0025;)</td>
<td valign="top" align="center">1.00</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;&#x003E;2,000&#x2009;mg</td>
<td valign="top" align="center">128 (89.51&#x0025;)</td>
<td valign="top" align="center">56 (90.32&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left" colspan="4">ARCO staging</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Stage 1</td>
<td valign="top" align="center">118 (82.52&#x0025;)</td>
<td valign="top" align="center">45 (72.58&#x0025;)</td>
<td valign="top" align="center">0.15</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Stage 2</td>
<td valign="top" align="center">25 (17.48&#x0025;)</td>
<td valign="top" align="center">17 (27.42&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left" colspan="4">NI</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;A and B</td>
<td valign="top" align="center">78 (54.55&#x0025;)</td>
<td valign="top" align="center">35 (56.45&#x0025;)</td>
<td valign="top" align="center">0.92</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;C</td>
<td valign="top" align="center">65 (45.45&#x0025;)</td>
<td valign="top" align="center">27 (43.55&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left" colspan="4">CJFH Classification</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;M, C, and L1</td>
<td valign="top" align="center">44 (30.77&#x0025;)</td>
<td valign="top" align="center">21 (33.87&#x0025;)</td>
<td valign="top" align="center">0.78</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;L2 and L3</td>
<td valign="top" align="center">99(69.23&#x0025;)</td>
<td valign="top" align="center">41(66.13&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F1" position="float"><label>Figure 1</label>
<caption><p>Schematic diagrams (top) and magnetic resonance images (bottom) of the China-Japan Friendship Hospital Classification of osteonecrosis of the femoral head based on the three pillars. Type M: Necrosis involves the medial pillar. Type C: Necrosis involves the medial and central pillars. Type L1: Necrosis involves all three pillars, but the lateral pillar is partially preserved. Type L2: Necrosis involves the entire lateral pillar and part of the central pillar. Type L3: Necrosis involves all three pillars, including the cortical bone and marrow.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fsurg-11-1333646-g001.tif"/>
</fig>
<p>The NI, which was first proposed by Koo et al (<xref ref-type="bibr" rid="B13">13</xref>), is a method that uses MRI to estimate the extent of necrosis in the mid-coronal image (A) and midsagittal image (B), using the formula as follows: (A/180)&#x2009;&#x00D7;&#x2009;(B/180)&#x2009;&#x00D7;&#x2009;100. The index of necrotic extent is classified into three grades based on the value: Grade A, small necrosis, &#x2264;33; Grade B, medium necrosis, 34&#x2013;66; and Grade C, large necrosis, 67&#x2013;100. This method can predict the subsequent risk of femoral head collapse (<xref ref-type="bibr" rid="B14">14</xref>).</p>
<p>The ARCO developed the first ARCO Staging system based on the system of Ficat and Arlet and Steinberg classification in 1991. In our study, we used the 2019 revised staging system of ONFH based on the 1994 ARCO Staging system, which includes the following four stages: Stage 1, x-ray is normal, but MRI or bone scan is positive; Stage 2, x-ray is abnormal (subtle signs of osteosclerosis, focal osteoporosis, or cystic change in the femoral head), but without subchondral fracture, fracture in the necrotic portion, or flattening of the femoral head; Stage 3, x-ray or CT scans reveal a fracture in the subchondral or necrotic zone (Stage 3A, early, femoral head depression &#x2264;2&#x2005;mm; Stage 3B, late, femoral head depression &#x003E;2&#x2005;mm); and Stage 4, x-ray reveals osteoarthritis with accompanying joint space narrowing, acetabular changes, and/or joint destruction (<xref ref-type="bibr" rid="B7">7</xref>). In our study, all patients with glucocorticoid-induced ONFH at diagnosis were classified as Stage 1 or 2 based on the ARCO Staging, which is considered early-stage lesions.</p>
<p>The endpoint in this study was the duration from the time of diagnosis to femoral head collapse for ONFH. Collapse was defined as progression from ARCO Stage 1 or 2 to Stage 3 or 4 (subchondral fracture on x-ray or CT or x-ray osteoarthritis). The presentive MRI (T1WIs and T2WIs) and x-ray films are shown in <xref ref-type="fig" rid="F2">Figure&#x00A0;2</xref>.</p>
<fig id="F2" position="float"><label>Figure 2</label>
<caption><p>The presentive MRI (T1WIs and T2WIs) and x-ray films at diagnosis and endpoint. (<bold>A</bold>) Imaging at diagnosis: a limited subchondral linear-shaped low signal intensity in T1WIs and a &#x201C;double-line sign&#x201D; in T2-weighted images in MRI and an AP view of bilateral hips, no signs of collapse in x-ray films (ARCO Stage 1). (<bold>B</bold>) Imaging at the endpoint: subtle signs of osteosclerosis (right, ARCO Stage 2), fracture in the subchondral zone and femoral head depression &#x2264;2&#x2005;mm (left, ARCO Stage 3A), mottled appearance of femoral head and osteosclerosis in bilateral hips in x-ray films. The black arrowhead shows the collapse position.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fsurg-11-1333646-g002.tif"/>
</fig>
</sec>
<sec id="s2c"><label>2.3</label><title>Statistical analysis</title>
<p>All eligible patients were divided into the training cohort (143 hips) and the validation cohort (62 hips) randomly. The continuous variables were expressed as mean(SD) and compared using an unpaired, two-tailed <italic>t</italic>-test or Mann&#x2013;Whitney <italic>U</italic> test. The categorical variables were compared using the <italic>&#x03C7;</italic><sup>2</sup> test or Fisher exact test. Each variable in the training cohort was assessed by univariate logistic regression analysis to investigate the independent risk factor, and a multivariate logistic regression model was used to evaluate the independent prognostic factors of femoral head collapse in patients with glucocorticoid-induced ONFH.</p>
<p>Then a nomogram was formulated based on the results of multivariate logistic regression analysis and by using the rms package of R (Appendix 1). The predictive performance of the nomogram was measured by concordance index (C index) and calibration with 1,000 bootstrap samples to decrease the overfit bias (<xref ref-type="bibr" rid="B15">15</xref>). A C index of 0.5 indicated that the model had no predictive effect. The closer the C index was to 1, the better the predicted results of the model. The nomogram was applied in the validation cohort, to test using the C index and calibration plots.</p>
<p>Decision curve analysis (DCA) is a method for evaluating the clinical benefit of alternative models and was applied to nomograms by quantifying net benefits at different threshold probabilities. The treat-all-patients scheme curve (representing the highest clinical costs) and the treat-none scheme curve (representing no clinical benefit) were plotted as two reference lines (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>).</p>
<p>In all analyses, <italic>P</italic>&#x2009;&#x003C;&#x2009;0.05 was considered to indicate statistical significance. All analysis was performed using R, version 4.2.3 (<ext-link ext-link-type="uri" xlink:href="http://www.r-project.org/">http://www.r-project.org/</ext-link>). Data analysis was conducted from 8 September to 20 November 2022.</p>
</sec>
</sec>
<sec id="s3"><label>3</label><title>Result</title>
<sec id="s3a"><label>3.1</label><title>Patient baseline characteristics</title>
<p>There were 120 patients (205 hips) with glucocorticoid-induced ONFH enrolled in the statistical analysis. <xref ref-type="table" rid="T1">Table&#x00A0;1</xref> lists the demographic and imageological characteristics of the training and validation cohorts. There was no significant difference between the training and validation cohorts.</p>
</sec>
<sec id="s3b"><label>3.2</label><title>Logistic regression analysis for prognostic factors of femoral head collapse</title>
<p>Univariate and multivariate regression analyses were performed to investigate the independent prognostic factor for femoral head collapse in patients with glucocorticoid-induced ONFH. The clinical variables under statistical analysis were as follows: age at diagnosis, height at diagnosis, weight at diagnosis, BMI at diagnosis, sex, accumulated dose of CS, ARCO Staging, NI, and CJFH Classification. <xref ref-type="table" rid="T2">Table&#x00A0;2</xref> presents the detailed results.</p>
<table-wrap id="T2" position="float"><label>Table 2</label>
<caption><p>Univariate logistic regression analysis of variables with glucocorticoid-induced ONFH in the training cohort.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Variable</th>
<th valign="top" align="center">OR (95&#x0025; Cl)</th>
<th valign="top" align="center"><italic>P</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Age (years)</td>
<td valign="top" align="center">0.98 (0.93&#x2013;1.02)</td>
<td valign="top" align="center">0.31</td>
</tr>
<tr>
<td valign="top" align="left">Height (cm)</td>
<td valign="top" align="center">0.98 (0.92&#x2013;1.06)</td>
<td valign="top" align="center">0.73</td>
</tr>
<tr>
<td valign="top" align="left">Weight (kg)</td>
<td valign="top" align="center">0.99 (0.94&#x2013;1.04)</td>
<td valign="top" align="center">0.72</td>
</tr>
<tr>
<td valign="top" align="left">BMI (kg/m<sup>2</sup>)</td>
<td valign="top" align="center">0.99 (0.79&#x2013;1.30)</td>
<td valign="top" align="center">0.91</td>
</tr>
<tr>
<td valign="top" align="left">Sex, male vs. female</td>
<td valign="top" align="center">1.09 (0.57&#x2013;2.07)</td>
<td valign="top" align="center">0.78</td>
</tr>
<tr>
<td valign="top" align="left">Accumulated dose of CS, &#x2264;2,000&#x2005;mg vs. &#x003E;2,000&#x2005;mg</td>
<td valign="top" align="center">4.86 (0.92&#x2013;89.81)</td>
<td valign="top" align="center">0.13</td>
</tr>
<tr>
<td valign="top" align="left">NI, A and B vs. C</td>
<td valign="top" align="center">15.86 (5.73&#x2013;56.52)</td>
<td valign="top" align="center">1.3&#x002A;10<sup>&#x2212;6</sup></td>
</tr>
<tr>
<td valign="top" align="left">CJFH Classification, M, C, and L1 vs. L2 and L3</td>
<td valign="top" align="center">27.13 (10.29&#x2013;82.54)</td>
<td valign="top" align="center">3.2&#x002A;10<sup>&#x2212;10</sup></td>
</tr>
<tr>
<td valign="top" align="left">ARCO Staging, Stage 1 vs. Stage 2</td>
<td valign="top" align="center">9.88 (3.88&#x2013;26.77)</td>
<td valign="top" align="center">2.8&#x002A;10<sup>&#x2212;6</sup></td>
</tr>
</tbody>
</table>
</table-wrap>
<p>From the results of univariate analysis, we found that ARCO Staging, NI, and CJFH Classification (<italic>P</italic>&#x2009;&#x003C;&#x2009;0.05) were associated with the prognosis of glucocorticoid-induced ONFH. In multivariate analysis, the results (<xref ref-type="table" rid="T3">Table&#x00A0;3</xref>) revealed that ARCO Staging, Stage 2 (OR&#x2009;&#x003D;&#x2009;4.44, 95&#x0025; Cl: 1.38&#x2013;15.2; <italic>P</italic>&#x2009;&#x003D;&#x2009;0.014); NI, Grade C (OR&#x2009;&#x003D;&#x2009;6.19, 95&#x0025; Cl: 1.79&#x2013;25.69; <italic>P</italic>&#x2009;&#x003D;&#x2009;0.006); and CJFH Classification, Types L2 and L3 [(OR&#x2009;&#x003D;&#x2009;12.65, 95&#x0025; Cl: 4.34&#x2013;41.61; <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001)] were independently associated with collapse of femoral head. These three variables were used to develop the nomogram (<xref ref-type="fig" rid="F3">Figure&#x00A0;3</xref>). The resulting model was internally validated using the bootstrap validation method. There was a good calibration curve for prediction (<xref ref-type="fig" rid="F4">Figure&#x00A0;4</xref>). The nomogram demonstrated good accuracy in estimating the probability of the femoral head collapse, with an unadjusted C index of 0.908 (95&#x0025; CI, 0.853&#x2013;0.962) and a bootstrap-corrected C index of 0.901. In the validation cohort, the nomogram showed a C index of 0.876 (95&#x0025; CI: 0.7751&#x2013;0.9761) for predicting the probability of collapse. There was also a good calibration curve for prediction (<xref ref-type="fig" rid="F5">Figure&#x00A0;5</xref>). DCA was used to assess whether a nomogram would help with clinical treatment strategies. In our study, when the threshold probability varied from 0 to 1, the nomogram achieved good net benefit according to the DCA (<xref ref-type="fig" rid="F6">Figure&#x00A0;6</xref>).</p>
<table-wrap id="T3" position="float"><label>Table 3</label>
<caption><p>Multivariate logistic regression analysis of variables with glucocorticoid-induced ONFH in the training cohort.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Variable</th>
<th valign="top" align="center">OR (95&#x0025; Cl)</th>
<th valign="top" align="center"><italic>P</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">NI, Grades A and B vs. C</td>
<td valign="top" align="center">6.19 (1.79&#x2013;25.69)</td>
<td valign="top" align="center">0.006</td>
</tr>
<tr>
<td valign="top" align="left">CJFH Classification, Type M, C, and L1 vs. L2 and L3</td>
<td valign="top" align="center">12.65 (4.34&#x2013;41.61)</td>
<td valign="top" align="center">8.5&#x2005;&#x002A;&#x2005;10<sup>&#x2212;6</sup></td>
</tr>
<tr>
<td valign="top" align="left">ARCO Staging, Stage 1 vs. Stage 2</td>
<td valign="top" align="center">4.44 (1.38&#x2013;15.2)</td>
<td valign="top" align="center">0.014</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F3" position="float"><label>Figure 3</label>
<caption><p>Nomogram of the probability of femoral head collapse in patients with glucocorticoid-induced ONFH.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fsurg-11-1333646-g003.tif"/>
</fig>
<fig id="F4" position="float"><label>Figure 4</label>
<caption><p>Calibration plot for predicting the probability of femoral head collapse in the training cohort.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fsurg-11-1333646-g004.tif"/>
</fig>
<fig id="F5" position="float"><label>Figure 5</label>
<caption><p>Calibration plot for predicting the probability of femoral head collapse in the validation cohort.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fsurg-11-1333646-g005.tif"/>
</fig>
<fig id="F6" position="float"><label>Figure 6</label>
<caption><p>Decision curve analysis (DCA) based on nomogram.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fsurg-11-1333646-g006.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion"><label>4</label><title>Discussion</title>
<p>The nomograms have been widely applied in predicting the prognosis of many kinds of diseases, particularly in cancer prognosis, on account of the ability to simplify statistical predictive models into a single numerical estimate of the probability of an event, such as death or recurrence, which is tailored to the profile of an individual patient (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). Our study first constructed the nomogram for predicting the probability of femoral head collapse in glucocorticoid-induced ONFH and illustrated the clinical practical value of the NI, CJFH Classification, and ARCO Staging.</p>
<p>Collapse of the femoral head results in marked deterioration of hip function which is extremely difficult to be treated by hip preserving procedures. The aim of treatment in the early stages is to preserve the femoral head because when femoral head collapse occurs, femoral head preserving procedures have a poor prognosis and THA is usually required (<xref ref-type="bibr" rid="B20">20</xref>). The early and peri-collapse stage with distinct clinical and imaging characteristics provides a last good opportunity for joint-preserving techniques (<xref ref-type="bibr" rid="B21">21</xref>). The nomogram of our study suggests ARCO Staging, NI, and CJFH Classification are significantly associated with the collapse of the femoral head in patients with glucocorticoid-induced ONFH. For example, if a patient is diagnosed with Stage 1 of ARCO Staging (0 points), Grade C of NI (72 points), and Type L3 of CJFH Classification (100 points), the total score is 172 points. The probability of femoral head collapse is about 61&#x0025; in this case.</p>
<p>The previous studies suggested that osteonecrosis incidence was 6.7&#x0025; with corticosteroid treatment of &#x003E;2,000&#x2005;mg (prednisone-equivalent) (<xref ref-type="bibr" rid="B22">22</xref>), and there was an obvious dose&#x2013;duration&#x2013;response relationship between CS and ONFH (<xref ref-type="bibr" rid="B21">21</xref>). Therefore, we chose 2,000&#x2005;mg as the point of accumulated dose of CS in our research and found that there is no statistical significance (<italic>P</italic>&#x2009;&#x003D;&#x2009;0.13), which indicated that there was no obvious dose-response relationship between the accumulated dose of CS and femoral head collapse. A 10-year minimum follow-up study in patients of SLE with asymptomatic osteonecrosis showed that the spontaneous repair of ONFH has no relationship with cumulative dose of CS, mean dose of CS over time, or duration of CS therapy (<xref ref-type="bibr" rid="B23">23</xref>).</p>
<p>As finite element analysis has confirmed that the lateral pillar is the main biomechanical support of the femoral head (<xref ref-type="bibr" rid="B24">24</xref>), the CJFH Classification which emphasizes the significance lateral pillar could be a crucial factor in predicting the femoral head collapse. The result of logistic regression analysis in our study (Type M, C, L1 vs. Types L2 and L3) proved this hypothesis well (OR&#x2009;&#x003D;&#x2009;12.65, 95&#x0025; Cl: 4.34&#x2013;41.61; <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001). Although the necrosis involves all three pillars in Type L, the lateral pillar is partially preserved in Type L1, and necrosis involves the entire lateral pillar in Types L2 and L3. Data analysis indicated that the probability of the femoral head collapse in Type M, C, and L1 was significantly lower than that in Types L2 and L3, which was in accordance with the emphasis on the significance of the lateral pillar of the femoral head in CJFH Classification. Compared with the Japanese Investigation Committee (JIC) classification (<xref ref-type="bibr" rid="B25">25</xref>), the CJFH Classification is performed directly on the femoral head, which could help avoid defects in anatomical variation, developmental dysplasia, and poor alignment of the hip (<xref ref-type="bibr" rid="B8">8</xref>). In a study of 2,800 evaluations performed according to the CJFH Classification, the average interobserver kappa value was 0.711, and 400 assessments were performed with an average intraobserver kappa value of 0.748, indicating that the CJFH Classification system is a reliable, simple, and convenient clinical evaluation model with substantial inter- and intraobserver reliability, and its rational application may improve the prognosis of ONFH (<xref ref-type="bibr" rid="B26">26</xref>). The combination of NI and CJFH Classification in the nomogram evaluates the necrotic extent from the coronal median plane and sagittal median plane and also clarifies the positional relationship between the necrotic area and the three pillars, which is a more comprehensive, accurate, and systematic assessment method. The 2019 revised version of ARCO Staging was developed by an expert group led by Kyung-Hoi Koo, which has had a great change in the ARCO Staging system since 1994 (<xref ref-type="bibr" rid="B7">7</xref>). The features of the revised ARCO Staging system defined Stages 1 and 2 as early-stage lesions, which are also known as subclinical stages for the reason that lesions at these stages are often insidious and the symptoms and signs are minimal and non-specific (<xref ref-type="bibr" rid="B21">21</xref>). Our study shows that the femoral head in Stage 2 is more likely to collapse than that in Stage 1 (OR&#x2009;&#x003D;&#x2009;4.44, 95&#x0025; Cl: 1.38&#x2013;15.2; <italic>P</italic>&#x2009;&#x003D;&#x2009;0.014) and the femoral head in Stage 1 tends to spontaneously repair.</p>
<p>However, in clinical work, those patients in the early stage often choose to wait and watch until miss the critical window of opportunity to preserve the native hip joint. Meanwhile, surgical interventions of asymptomatic ONFH, such as core decompression, and non-vascularized or vascularized bone-grafting (<xref ref-type="bibr" rid="B27">27</xref>&#x2013;<xref ref-type="bibr" rid="B29">29</xref>) are controversial due to the probability of spontaneous repair of necrotic lesions and great variability of progression at the early stage (7&#x0025; of small and 80&#x0025; of large lesions collapsed by 8 years) (<xref ref-type="bibr" rid="B30">30</xref>), and efficacy of those operative treatments is still disputable (<xref ref-type="bibr" rid="B31">31</xref>). Though orthopedic surgery is important for the treatment of glucocorticoid-induced ONFH, its prognosis is rather poor and unpredictable (<xref ref-type="bibr" rid="B32">32</xref>). Therefore, the probability of femoral head collapse given by the nomogram could help doctors make individualized treatment plans whether a surgical intervention is required after evaluating the probability of the femoral head collapse. If surgical treatment isn&#x2019;t necessary, non-surgical treatments such as protective weight-bearing, drug treatment, and physical therapy including extracorporeal shock wave therapy might be the optimal treatment choice (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B33">33</xref>).</p>
<p>Although the current study provides useful information on the value of using a nomogram to predict the probability of femoral head collapse in patients with glucocorticoid-induced ONFH, it has some limitations that need to be acknowledged. Firstly, the nomogram was based on a retrospective study conducted at a single center, which may limit its applicability to other populations. Therefore, it is necessary to validate the results from other centers to increase its generalizability. Secondly, although the study is a retrospective cohort study in SARS patients with glucocorticoid-induced ONFH, it is still valuable for predicting femoral head collapse caused by other risk factors associated with ONFH such as alcohol abuse, smoking, SLE, non-steroidal chemotherapeutic agents for leukemia and other myelogenous diseases. One of the reasons we chose the glucocorticoid-induced ONFH to construct the nomogram is that glucocorticoid use is the most common cause of ONFH (<xref ref-type="bibr" rid="B34">34</xref>). The ONFH caused by different risk factors may lead to the same pathogenesis when it comes to the collapse of necrotic bone at last (<xref ref-type="bibr" rid="B35">35</xref>), and our study should be applied to ONFH caused by other risk factors. Overall, while the current study provides valuable insights into the use of a nomogram for predicting the probability of femoral head collapse, further research is needed to validate and generalize these findings.</p>
</sec>
<sec id="s5" sec-type="conclusions"><label>5</label><title>Conclusions</title>
<p>By combining three factors, ARCO Staging, NI, and CJFH Classification of glucocorticoid-induced ONFH, the nomogram was constructed. The model provides an estimation of the probability of femoral head collapse in patients with glucocorticoid-induced ONFH. Although our nomogram was internally validated by bootstrap validation with 1,000 resampling runs and assessed in another validation cohort, further research is needed to externally validate our nomogram. The nomogram developed in our study will contribute to the treatment of glucocorticoid-induced ONFH in the early stage.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability"><title>Data availability statement</title>
<p>The datasets analyzed in this study are available on reasonable request from the corresponding author. Requests to access these datasets should be directed to FG, <email>gaofuqiang@bjmu.edu.cn</email>.</p>
</sec>
<sec id="s7" sec-type="ethics-statement"><title>Ethics statement</title>
<p>The studies involving humans were approved by the Ethics committee of China Japan Friendship Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s8" sec-type="author-contributions"><title>Author contributions</title>
<p>RQ: Data curation, Methodology, Software, Writing &#x2013; original draft. FG: Conceptualization, Data curation, Funding acquisition, Writing &#x2013; review &#x0026; editing. WS: Conceptualization, Funding acquisition, Writing &#x2013; review &#x0026; editing. ZL: Project administration, Supervision, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec id="s9" sec-type="funding-information"><title>Funding</title>
<p>The authors declare financial support was received for the research, authorship, and/or publication of this article.</p>
<p>This study was supported by the National High Level Hospital Clinical Research Funding (2022-NHLHCRF-PY-20), China-Japan Friendship Hospital Horizontal Project/Spontaneous Research Funding (2022-HX-JC-7), National Natural Science Foundation of China (81672236 and 81871830), the Beijing Natural Science Foundation (7182146), Joint Project of BRC-BC (Biomedical Translational Engineering Research Center of BUCT-CJFH) (RZ2020-02), and Elite Medical Professionals project of China-Japan Friendship Hospital (No. ZRJY2021-GG12).</p>
</sec>
<sec id="s10" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s12" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>DW</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Hu</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>BJ</given-names></name><etal/></person-group> <article-title>Prevalence of nontraumatic osteonecrosis of the femoral head and its associated risk factors in the Chinese population: results from a nationally representative survey</article-title>. <source>Chin Med J</source>. (<year>2015</year>) <volume>128</volume>(<issue>21</issue>):<fpage>2843</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.4103/0366-6999.168017</pub-id><pub-id pub-id-type="pmid">26521779</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>NF</given-names></name><name><surname>Li</surname><given-names>ZR</given-names></name><name><surname>Wei</surname><given-names>HY</given-names></name><name><surname>Liu</surname><given-names>ZH</given-names></name><name><surname>Hernigou</surname><given-names>P</given-names></name></person-group>. <article-title>Steroid-induced osteonecrosis: the number of lesions is related to the dosage</article-title>. <source>J Bone Joint Surg Br</source>. (<year>2008</year>) <volume>90</volume>(<issue>9</issue>):<fpage>1239</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1302/0301-620X.90B9.20056</pub-id><pub-id pub-id-type="pmid">18757967</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>FC</given-names></name><name><surname>Li</surname><given-names>ZR</given-names></name><name><surname>Zhang</surname><given-names>NF</given-names></name><name><surname>Wang</surname><given-names>BL</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Cheng</surname><given-names>LM</given-names></name><etal/></person-group> <article-title>Lesion size changes in osteonecrosis of the femoral head: a long-term prospective study using MRI</article-title>. <source>Int Orthop</source>. (<year>2010</year>) <volume>34</volume>(<issue>6</issue>):<fpage>799</fpage>&#x2013;<lpage>804</lpage>. <pub-id pub-id-type="doi">10.1007/s00264-009-0829-7</pub-id><pub-id pub-id-type="pmid">19533123</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>ZR</given-names></name><name><surname>Shi</surname><given-names>ZC</given-names></name><name><surname>Zhang</surname><given-names>NF</given-names></name><name><surname>Zhang</surname><given-names>YC</given-names></name></person-group>. <article-title>Changes in coagulation and fibrinolysis of post-SARS osteonecrosis in a Chinese population</article-title>. <source>Int Orthop</source>. (<year>2006</year>) <volume>30</volume>(<issue>3</issue>):<fpage>143</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1007/s00264-005-0067-6</pub-id><pub-id pub-id-type="pmid">16547717</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lieberman</surname><given-names>JR</given-names></name><name><surname>Berry</surname><given-names>DJ</given-names></name><name><surname>Mont</surname><given-names>MA</given-names></name><name><surname>Aaron</surname><given-names>RK</given-names></name><name><surname>Callaghan</surname><given-names>JJ</given-names></name><name><surname>Rajadhyaksha</surname><given-names>AD</given-names></name><etal/></person-group> <article-title>Osteonecrosis of the hip: management in the 21st century</article-title>. <source>Instr Course Lect</source>. (<year>2003</year>) <volume>52</volume>:<fpage>337</fpage>&#x2013;<lpage>55</lpage>.<pub-id pub-id-type="pmid">12690862</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mont</surname><given-names>MA</given-names></name><name><surname>Jones</surname><given-names>LC</given-names></name><name><surname>Hungerford</surname><given-names>DS</given-names></name></person-group>. <article-title>Nontraumatic osteonecrosis of the femoral head: ten years later</article-title>. <source>J Bone Joint Surg Am</source>. (<year>2006</year>) <volume>88</volume>(<issue>5</issue>):<fpage>1117</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.2106/JBJS.E.01041</pub-id><pub-id pub-id-type="pmid">16651589</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>BH</given-names></name><name><surname>Mont</surname><given-names>MA</given-names></name><name><surname>Koo</surname><given-names>KH</given-names></name><name><surname>Chen</surname><given-names>CH</given-names></name><name><surname>Cheng</surname><given-names>EY</given-names></name><name><surname>Cui</surname><given-names>Q</given-names></name><etal/></person-group> <article-title>The 2019 revised version of Association Research Circulation Osseous Staging System of Osteonecrosis of the Femoral Head</article-title>. <source>J Arthroplasty</source>. (<year>2020</year>) <volume>35</volume>(<issue>4</issue>):<fpage>933</fpage>&#x2013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.arth.2019.11.029</pub-id><pub-id pub-id-type="pmid">31866252</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Shi</surname><given-names>ZC</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Zhao</surname><given-names>F</given-names></name><etal/></person-group> <article-title>The classification of osteonecrosis of the femoral head based on the three pillars structure: China-Japan Friendship Hospital (CJFH) classification</article-title>. <source>China J Orthop</source>. (<year>2012</year>) <volume>32</volume>(<issue>06</issue>):<fpage>13</fpage>&#x2013;<lpage>22</lpage>.</citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>CT</given-names></name></person-group>. <article-title>The lateral pillar classification for Legg-Calv&#x00E9;-Perthes disease</article-title>. <source>J Pediatr Orthop</source>. (<year>2007</year>) <volume>27</volume>(<issue>5</issue>):<fpage>592</fpage>&#x2013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1097/01.bpb.0000279028.74397.02</pub-id><pub-id pub-id-type="pmid">17585273</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Hong</surname><given-names>G</given-names></name><name><surname>Fang</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Guan</surname><given-names>T</given-names></name><etal/></person-group> <article-title>Predicting the collapse of the femoral head due to osteonecrosis: from basic methods to application prospects</article-title>. <source>J Orthop Translat</source>. (<year>2017</year>) <volume>11</volume>:<fpage>62</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.jot.2016.11.002</pub-id><pub-id pub-id-type="pmid">29662770</pub-id></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Si</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan criteria</article-title>. <source>JAMA Surg</source>. (<year>2016</year>) <volume>151</volume>(<issue>4</issue>):<fpage>356</fpage>&#x2013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1001/jamasurg.2015.4257</pub-id><pub-id pub-id-type="pmid">26579636</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Shi</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Gao</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><etal/></person-group> <article-title>Relationship between post-SARS osteonecrosis and PAI-1 4G/5G gene polymorphisms</article-title>. <source>Eur J Orthop Surg Traumatol</source>. (<year>2014</year>) <volume>24</volume>(<issue>4</issue>):<fpage>525</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/s00590-013-1223-0</pub-id><pub-id pub-id-type="pmid">23589033</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname><given-names>KH</given-names></name><name><surname>Kim</surname><given-names>R</given-names></name></person-group>. <article-title>Quantifying the extent of osteonecrosis of the femoral head. A new method using MRI</article-title>. <source>J Bone Joint Surg Br</source>. (<year>1995</year>) <volume>77</volume>(<issue>6</issue>):<fpage>875</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1302/0301-620X.77B6.7593098</pub-id><pub-id pub-id-type="pmid">7593098</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname><given-names>KH</given-names></name><name><surname>Kim</surname><given-names>R</given-names></name><name><surname>Ko</surname><given-names>GH</given-names></name><name><surname>Song</surname><given-names>HR</given-names></name><name><surname>Jeong</surname><given-names>ST</given-names></name><name><surname>Cho</surname><given-names>SH</given-names></name></person-group>. <article-title>Preventing collapse in early osteonecrosis of the femoral head. A randomised clinical trial of core decompression</article-title>. <source>J Bone Joint Surg Br</source>. (<year>1995</year>) <volume>77</volume>(<issue>6</issue>):<fpage>870</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1302/0301-620X.77B6.7593097</pub-id><pub-id pub-id-type="pmid">7593097</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steyerberg</surname><given-names>EW</given-names></name><name><surname>Vergouwe</surname><given-names>Y</given-names></name></person-group>. <article-title>Towards better clinical prediction models: seven steps for development and an ABCD for validation</article-title>. <source>Eur Heart J</source>. (<year>2014</year>) <volume>35</volume>(<issue>29</issue>):<fpage>1925</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehu207</pub-id><pub-id pub-id-type="pmid">24898551</pub-id></citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fitzgerald</surname><given-names>M</given-names></name><name><surname>Saville</surname><given-names>BR</given-names></name><name><surname>Lewis</surname><given-names>RJ</given-names></name></person-group>. <article-title>Decision curve analysis</article-title>. <source>JAMA</source>. (<year>2015</year>) <volume>313</volume>(<issue>4</issue>):<fpage>409</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2015.37</pub-id><pub-id pub-id-type="pmid">25626037</pub-id></citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vickers</surname><given-names>AJ</given-names></name><name><surname>Elkin</surname><given-names>EB</given-names></name></person-group>. <article-title>Decision curve analysis: a novel method for evaluating prediction models</article-title>. <source>Med Decis Making</source>. (<year>2006</year>) <volume>26</volume>(<issue>6</issue>):<fpage>565</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1177/0272989X06295361</pub-id></citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iasonos</surname><given-names>A</given-names></name><name><surname>Schrag</surname><given-names>D</given-names></name><name><surname>Raj</surname><given-names>GV</given-names></name><name><surname>Panageas</surname><given-names>KS</given-names></name></person-group>. <article-title>How to build and interpret a nomogram for cancer prognosis</article-title>. <source>J Clin Oncol</source>. (<year>2008</year>) <volume>26</volume>(<issue>8</issue>):<fpage>1364</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1200/JCO.2007.12.9791</pub-id><pub-id pub-id-type="pmid">18323559</pub-id></citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>YY</given-names></name><name><surname>Jia</surname><given-names>YT</given-names></name><name><surname>He</surname><given-names>JL</given-names></name><name><surname>Dai</surname><given-names>GY</given-names></name><name><surname>Guo</surname><given-names>P</given-names></name><etal/></person-group> <article-title>A nomogram model for predicting prognosis of obstructive colorectal cancer</article-title>. <source>World J Surg Oncol</source>. (<year>2021</year>) <volume>19</volume>(<issue>1</issue>):<fpage>337</fpage>. <pub-id pub-id-type="doi">10.1186/s12957-021-02445-6</pub-id><pub-id pub-id-type="pmid">34857001</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ansari</surname><given-names>S</given-names></name><name><surname>Goyal</surname><given-names>T</given-names></name><name><surname>Kalia</surname><given-names>RB</given-names></name><name><surname>Paul</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name></person-group>. <article-title>Prediction of collapse in femoral head osteonecrosis: role of volumetric assessment</article-title>. <source>Hip Int</source>. (<year>2022</year>) <volume>32</volume>(<issue>5</issue>):<fpage>596</fpage>&#x2013;<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1177/1120700020978587</pub-id><pub-id pub-id-type="pmid">33334177</pub-id></citation></ref>
<ref id="B21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>QY</given-names></name><name><surname>Li</surname><given-names>ZR</given-names></name><name><surname>Gao</surname><given-names>FQ</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name></person-group>. <article-title>Pericollapse stage of osteonecrosis of the femoral head: a last chance for joint preservation</article-title>. <source>Chin Med J</source>. (<year>2018</year>) <volume>131</volume>(<issue>21</issue>):<fpage>2589</fpage>&#x2013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.4103/0366-6999.244111</pub-id><pub-id pub-id-type="pmid">30381593</pub-id></citation></ref>
<ref id="B22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mont</surname><given-names>MA</given-names></name><name><surname>Pivec</surname><given-names>R</given-names></name><name><surname>Banerjee</surname><given-names>S</given-names></name><name><surname>Issa</surname><given-names>K</given-names></name><name><surname>Elmallah</surname><given-names>RK</given-names></name><name><surname>Jones</surname><given-names>LC</given-names></name></person-group>. <article-title>High-dose corticosteroid use and risk of hip osteonecrosis: meta-analysis and systematic literature review</article-title>. <source>J Arthroplasty</source>. (<year>2015a</year>) <volume>30</volume>(<issue>9</issue>):<fpage>1506</fpage>&#x2013;<lpage>1512.e5</lpage>. <pub-id pub-id-type="doi">10.1016/j.arth.2015.03.036</pub-id><pub-id pub-id-type="pmid">25900167</pub-id></citation></ref>
<ref id="B23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>J</given-names></name><name><surname>Harada</surname><given-names>Y</given-names></name><name><surname>Oinuma</surname><given-names>K</given-names></name><name><surname>Iida</surname><given-names>S</given-names></name><name><surname>Kishida</surname><given-names>S</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name></person-group>. <article-title>Spontaneous repair of asymptomatic osteonecrosis associated with corticosteroid therapy in systemic lupus erythematosus: 10-year minimum follow-up with MRI</article-title>. <source>Lupus</source>. (<year>2010</year>) <volume>19</volume>(<issue>11</issue>):<fpage>1307</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1177/0961203310372951</pub-id><pub-id pub-id-type="pmid">20605878</pub-id></citation></ref>
<ref id="B24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>PF</given-names></name><name><surname>Guo</surname><given-names>WS</given-names></name><name><surname>Zhang</surname><given-names>QD</given-names></name><name><surname>Gao</surname><given-names>FQ</given-names></name><name><surname>Yue</surname><given-names>JA</given-names></name><name><surname>Liu</surname><given-names>ZH</given-names></name><etal/></person-group> <article-title>Significance of lateral pillar in osteonecrosis of femoral head: a finite element analysis</article-title>. <source>Chin Med J</source>. (<year>2017</year>) <volume>130</volume>(<issue>21</issue>):<fpage>2569</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.4103/0366-6999.217077</pub-id><pub-id pub-id-type="pmid">29067956</pub-id></citation></ref>
<ref id="B25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sugano</surname><given-names>N</given-names></name><name><surname>Atsumi</surname><given-names>T</given-names></name><name><surname>Ohzono</surname><given-names>K</given-names></name><name><surname>Kubo</surname><given-names>T</given-names></name><name><surname>Hotokebuchi</surname><given-names>T</given-names></name><name><surname>Takaoka</surname><given-names>K</given-names></name></person-group>. <article-title>The 2001 revised criteria for diagnosis, classification, and staging of idiopathic osteonecrosis of the femoral head</article-title>. <source>J Orthop Sci</source>. (<year>2002</year>) <volume>7</volume>(<issue>5</issue>):<fpage>601</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1007/s007760200108</pub-id><pub-id pub-id-type="pmid">12355139</pub-id></citation></ref>
<ref id="B26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>LH</given-names></name><name><surname>Li</surname><given-names>ZR</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>YT</given-names></name><name><surname>Gao</surname><given-names>FQ</given-names></name></person-group>. <article-title>Reliability and repeatability of the China-Japan Friendship Hospital typing classification for nontraumatic osteonecrosis of the femoral head</article-title>. <source>J Bone Joint Surg Am</source>. (<year>2022</year>) <volume>104</volume>(<issue>Suppl 2</issue>):<fpage>40</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.2106/JBJS.20.00051</pub-id><pub-id pub-id-type="pmid">35389904</pub-id></citation></ref>
<ref id="B27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mont</surname><given-names>MA</given-names></name><name><surname>Zywiel</surname><given-names>MG</given-names></name><name><surname>Marker</surname><given-names>DR</given-names></name><name><surname>McGrath</surname><given-names>MS</given-names></name><name><surname>Delanois</surname><given-names>RE</given-names></name></person-group>. <article-title>The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review</article-title>. <source>J Bone Joint Surg Am</source>. (<year>2010</year>) <volume>92</volume>(<issue>12</issue>):<fpage>2165</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.2106/JBJS.I.00575</pub-id><pub-id pub-id-type="pmid">20844158</pub-id></citation></ref>
<ref id="B28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><etal/></person-group> <article-title>Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version)</article-title>. <source>J Orthop Translat</source>. (<year>2020</year>) <volume>21</volume>:<fpage>100</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.jot.2019.12.004</pub-id><pub-id pub-id-type="pmid">32309135</pub-id></citation></ref>
<ref id="B29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>DW</given-names></name><name><surname>Hu</surname><given-names>YC</given-names></name></person-group>. <article-title>Chinese experts&#x2019; consensus on the diagnosis and treatment of osteonecrosis of the femoral head in adults</article-title>. <source>Orthop Surg</source>. (<year>2012</year>) <volume>4</volume>(<issue>3</issue>):<fpage>125</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1111/j.1757-7861.2012.00192.x</pub-id><pub-id pub-id-type="pmid">22927145</pub-id></citation></ref>
<ref id="B30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mont</surname><given-names>MA</given-names></name><name><surname>Cherian</surname><given-names>JJ</given-names></name><name><surname>Sierra</surname><given-names>RJ</given-names></name><name><surname>Jones</surname><given-names>LC</given-names></name><name><surname>Lieberman</surname><given-names>JR</given-names></name></person-group>. <article-title>Nontraumatic osteonecrosis of the femoral head: where do we stand today? A ten-year update</article-title>. <source>J Bone Joint Surg Am</source>. (<year>2015b</year>) <volume>97</volume>(<issue>19</issue>):<fpage>1604</fpage>&#x2013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.2106/JBJS.O.00071</pub-id><pub-id pub-id-type="pmid">26446969</pub-id></citation></ref>
<ref id="B31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>H</given-names></name><name><surname>Guan</surname><given-names>H</given-names></name><name><surname>Lai</surname><given-names>Y</given-names></name><name><surname>Qin</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group>. <article-title>Review of various treatment options and potential therapies for osteonecrosis of the femoral head</article-title>. <source>J Orthop Translat</source>. (<year>2016</year>) <volume>4</volume>:<fpage>57</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.jot.2015.09.005</pub-id><pub-id pub-id-type="pmid">30035066</pub-id></citation></ref>
<ref id="B32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>XH</given-names></name><name><surname>Wang</surname><given-names>XL</given-names></name><name><surname>Yang</surname><given-names>HL</given-names></name><name><surname>Zhao</surname><given-names>DW</given-names></name><name><surname>Qin</surname><given-names>L</given-names></name></person-group>. <article-title>Steroid-associated osteonecrosis: epidemiology, pathophysiology, animal model, prevention, and potential treatments (an overview)</article-title>. <source>J Orthop Translat</source>. (<year>2015</year>) <volume>3</volume>(<issue>2</issue>):<fpage>58</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.jot.2014.12.002</pub-id><pub-id pub-id-type="pmid">30035041</pub-id></citation></ref>
<ref id="B33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Gao</surname><given-names>F</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><etal/></person-group> <article-title>High-energy focused extracorporeal shock wave prevents the occurrence of glucocorticoid-induced osteonecrosis of the femoral head: a prospective randomized controlled trial</article-title>. <source>J Orthop Translat</source>. (<year>2022</year>) <volume>36</volume>:<fpage>145</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.jot.2022.08.002</pub-id><pub-id pub-id-type="pmid">36263382</pub-id></citation></ref>
<ref id="B34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>XS</given-names></name><name><surname>Zhuang</surname><given-names>QY</given-names></name><name><surname>Weng</surname><given-names>XS</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>J</given-names></name><name><surname>Qian</surname><given-names>WW</given-names></name></person-group>. <article-title>Etiological and clinical analysis of osteonecrosis of the femoral head in Chinese patients</article-title>. <source>Chin Med J</source>. (<year>2013</year>) <volume>126</volume>(<issue>2</issue>):<fpage>290</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.issn.0366-6999.20120663</pub-id><pub-id pub-id-type="pmid">23324279</pub-id></citation></ref>
<ref id="B35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>Q</given-names></name><name><surname>Jo</surname><given-names>WL</given-names></name><name><surname>Koo</surname><given-names>KH</given-names></name><name><surname>Cheng</surname><given-names>EY</given-names></name><name><surname>Drescher</surname><given-names>W</given-names></name><name><surname>Goodman</surname><given-names>SB</given-names></name><etal/></person-group> <article-title>ARCO consensus on the pathogenesis of non-traumatic osteonecrosis of the femoral head</article-title>. <source>J Korean Med Sci</source>. (<year>2021</year>) <volume>36</volume>(<issue>10</issue>):<fpage>e65</fpage>. <pub-id pub-id-type="doi">10.3346/jkms.2021.36.e65</pub-id><pub-id pub-id-type="pmid">33724736</pub-id></citation></ref></ref-list>
<app-group><app id="app1"><title>APPENDIX 1 Related computerized programs for nomogram with R</title>
<p>library (rms)</p>
<p>Set the parameters</p>
<p>ddist&#x2009;&#x003C;&#x2009;- datadist (train_cohort)</p>
<p>options (datadist&#x003D;&#x2019;ddist&#x2019;)</p>
<p>For Logistic Regression Model</p>
<p>f&#x2009;&#x003C;&#x2009;- lrm (y&#x223C;Smoke&#x002B;&#x2026;&#x2026;, data&#x2009;&#x003D;&#x2009;train_cohort, x&#x2009;&#x003D;&#x2009;T, y&#x2009;&#x003D;&#x2009;T)</p>
<p>For Nomogram</p>
<p>nom&#x2009;&#x003C;&#x2009;-nomogram(f,fun&#x2009;&#x003D;&#x2009;function(x)1/(1&#x2009;&#x002B;&#x2009;exp(&#x2212;x)),fun.at&#x2009;&#x003D;&#x2009;c(.001,.01,.05,seq(.1,.9,by&#x2009;&#x003D;&#x2009;.1),.95,.99,.999), lp&#x2009;&#x003D;&#x2009;F, funlabel&#x2009;&#x003D;&#x2009;&#x201C;Probability of glucocorticoid-induced ONFH&#x201D;)</p>
<p>plot (nom)</p>
<p>For Resampling Validation of Nomogram</p>
<p>validate (f, method&#x003D;&#x201D;boot&#x201D;, B&#x2009;&#x003D;&#x2009;1000, dxy&#x2009;&#x003D;&#x2009;T)</p>
<p>For Calibration Curve</p>
<p>cal&#x2009;&#x003C;&#x2009;- calibrate(f, method&#x2009;&#x003D;&#x2009;&#x201C;boot&#x201D;, B&#x2009;&#x003D;&#x2009;1000)</p>
<p>plot (cal)</p></app>
</app-group>
</back>
</article>